(MedPage Today) — A hydroablation device developed for benign prostatic hyperplasia (BPH) showed promise as a potential treatment aid for early prostate cancer, according to results of a preliminary study from China.
Men in active surveillance…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/114080
Author :
Publish date : 2025-02-04 22:21:32
Copyright for syndicated content belongs to the linked Source.
